Gutiérrez-Castrellón P - Search Results

1

[Bone mass accretion in healthy Mexican 6 to 12 year-olds measured by DEXA].

Montijo-Barrios E, Ramírez-Mayans J, García-Campos M, Díaz R, Sólomon-Santibañez G, Gutiérrez-Castrellón P. Montijo-Barrios E, et al. Salud Publica Mex. 2009 May-Jun;51(3):227-30. doi: 10.1590/s0036-36342009000300013. Salud Publica Mex. 2009. PMID: 19967308 Spanish.

2

[Clinical trial on the effect of buphenine, aminophenazone and diphenylpyraline hydrochloride in treating the common cold in children of 6 to 24 months of age].

Montijo-Barrios E, Cadena F, Ramírez-Mayans JA, Gutiérrez-Castrellón P. Montijo-Barrios E, et al. Rev Invest Clin. 2011 Jul-Aug;63(4):335-43. Rev Invest Clin. 2011. PMID: 22364032 Clinical Trial. Spanish.

3

[Efficacy and safety of astemizole in the treatment of allergic rhinitis and urticaria: a systematic review with meta-analysis].

Gutiérrez Castrellón P, Ramírez Mayans J, López Pérez G. Gutiérrez Castrellón P, et al. Rev Alerg Mex. 2005 May-Jun;52(3):113-26. Rev Alerg Mex. 2005. PMID: 16158785 Review. Spanish.

4

Efficacy and safety of clarithromycin in pediatric patients with upper respiratory infections: a systematic review with meta-analysis.

Gutiérrez-Castrellón P, Mayorga-Buitron JL, Bosch-Canto V, Solomon-Santibañez G, de Colsa-Ranero A. Gutiérrez-Castrellón P, et al. Rev Invest Clin. 2012 Mar-Apr;64(2):126-35. Rev Invest Clin. 2012. PMID: 22991774 Review.

5

[Integrative pediatrics and personalized at the National Institute of Pediatrics].

Solomon-Santibáñez G, Gutierrez-Castrellón P. Solomon-Santibáñez G, et al. Rev Invest Clin. 2011 Jan-Feb;63(1):5-7. Rev Invest Clin. 2011. PMID: 21585005 Spanish. No abstract available.

6

Cisapride and QTc interval in children.

Ramírez-Mayans J, Garrido-García LM, Huerta-Tecanhuey A, Gutierrez-Castrellón P, Cervantes-Bustamante R, Mata-Rivera N, Zárate-Mondragón F. Ramírez-Mayans J, et al. Pediatrics. 2000 Nov;106(5):1028-30. doi: 10.1542/peds.106.5.1028. Pediatrics. 2000. PMID: 11061771 Clinical Trial.

7

[Neonatal sepsis morbidity and mortality in a tertiary care hospital].

Rodríguez-Weber MA, López-Candiani C, Arredondo-García JL, Gutiérrez-Castrellón P, Sánchez-Arriaga F. Rodríguez-Weber MA, et al. Salud Publica Mex. 2003 Mar-Apr;45(2):90-5. doi: 10.1590/s0036-36342003000200004. Salud Publica Mex. 2003. PMID: 12736986 Spanish.

8

Immune response to nucleotide-supplemented infant formulae: systematic review and meta-analysis.

Gutiérrez-Castrellón P, Mora-Magaña I, Díaz-García L, Jiménez-Gutiérrez C, Ramirez-Mayans J, Solomon-Santibáñez GA. Gutiérrez-Castrellón P, et al. Br J Nutr. 2007 Oct;98 Suppl 1:S64-7. doi: 10.1017/S000711450783296X. Br J Nutr. 2007. PMID: 17922963 Review.

9

[Randomized clinical trials: variants, randomization methods, analysis, ethical issues and regulations].

Lazcano-Ponce E, Salazar-Martínez E, Gutiérrez-Castrellón P, Angeles-Llerenas A, Hernández-Garduño A, Viramontes JL. Lazcano-Ponce E, et al. Salud Publica Mex. 2004 Nov-Dec;46(6):559-84. doi: 10.1590/s0036-36342004000600012. Salud Publica Mex. 2004. PMID: 15624861 Review. Spanish. No abstract available.

10

[Plasma fibronectin in pediatric patients].

Maulén-Radován I, Gutiérrez-Castrellón P. Maulén-Radován I, et al. Rev Invest Clin. 1996 Mar-Apr;48(2):105-9. Rev Invest Clin. 1996. PMID: 8815493 Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

77 results

Search Page